Schizoaffective Disorders Completed Phase 4 Trials for Bupropion (DB01156)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00320723Nicotine Replacement Therapy for Smoking Cessation in SchizophreniaTreatment
NCT00320697Smoking Relapse Prevention in SchizophreniaTreatment